Introduction
============

Coronary artery disease (CAD) is a leading cause of mortality in developed countries, causing 7.3 million deaths in the year 2001 worldwide ([@b1-etm-0-0-3299]). It can be attributed to disturbances of the coronary circulation, a process that is responsible for the oxygen and nutrient supply to the myocardium, and may involve dysfunction within the microcirculation, in addition to the coronary arteries ([@b2-etm-0-0-3299]). The atherosclerotic plaques that develop along the inner walls of the coronary arteries are a direct cause of the disease, narrowing the arteries and reducing blood flow to the heart. Currently, single-photon emission computed tomography, cardiac magnetic resonance and positron emission tomography perfusion imaging are the three most commonly used diagnosis techniques ([@b3-etm-0-0-3299]), however, only 20% of CAD cases are diagnosed prior to a heart attack ([@b4-etm-0-0-3299]). Thus, there is an urgent requirement for a novel, more efficient and credible methods.

A biological network contains certain small, repeated and conserved network motifs that appear at significantly higher frequencies than random ones ([@b5-etm-0-0-3299]). Doncic and Skotheim ([@b6-etm-0-0-3299]) have reported that a three-gene motif within a complex network is capable of explaining yeast cellular state decisions in response to mating pheromones, suggesting that it may not be necessary to model the full complexity of biological networks when attempting to capture the molecular determinants of cellular behaviors. Furthermore, investigation of network motifs have proven useful for the prediction of protein-protein interaction ([@b7-etm-0-0-3299]), decomposition of hierarchical networks ([@b8-etm-0-0-3299]) and analysis of temporal gene expression patterns ([@b9-etm-0-0-3299]). Thus, the network motif-based method is a potential approach for future CAD research.

Microarray analysis is used to detect gene expression changes occurring in patients with CAD ([@b10-etm-0-0-3299],[@b11-etm-0-0-3299]); however, the reproducibility of single-gene methods is often poor ([@b12-etm-0-0-3299]). In the present study, a novel network motif-based approach was employed to select motifs associated with CAD occurrence, which is considered to be more reproducible and interpretable. Through comparing this method with a conventional individual differentially expressed gene (DEG)-based method for the classification of CAD and normal control samples, the aforementioned motif-based method was demonstrated to be efficient and credible.

Materials and methods
=====================

### Extraction and preprocessing of gene microarray data

Gene expression profile dataset GSE42148 was downloaded from the Gene Expression Omnibus (GEO; <http://www.ncbi.nlm.nih.gov/geo/>) database. The gene annotation platform used was GPL13607 Agilent-028004 SurePrint G3 Human GE 8×60K Microarray. The data were collected from the whole blood samples of 13 patients with CAD and 11 population-based asymptomatic controls. First, the extracted microarray data were subject to log~2~ conversion, followed by quantile standardization ([@b13-etm-0-0-3299]).

### Screening of common genes and construction of an integrated regulation network

Transcriptional regulation data comprising transcription factors and target genes were downloaded from Encyclopedia of DNA Elements ([@b14-etm-0-0-3299]). In addition, protein-protein interaction pairs were downloaded from the Human Protein Reference Database ([@b15-etm-0-0-3299]).

Transcriptional regulation data and protein-protein interaction data downloaded from the two databases (R 3.2.2; <https://www.r-project.org/>) were integrated to screen the common genes. Any gene that exists in only the regulation network or the protein-protein interaction network was removed. The retained common genes were further compared with those annotated from the gene microarrays to screen the same genes. Final-screened common genes and associated transcription factors were used to construct an integrated regulation network.

### Detection of significant three-node network motifs

Three-node network motifs that occurred at a significantly greater frequency compared with random networks in the constructed integrated network (P\<0.05) were detected using Fast Network Motif Detection (version 2.2; <http://theinf1.informatik.uni-jena.de/motifs/>) ([@b16-etm-0-0-3299]). The significance test was conducted over 1,000 randomized networks, and a motif including at least one transcription factor with P\<0.05 was considered to indicate a statistically significant difference.

### Screening of differential network motifs

R-package GlobalAncova software (<http://www.bioconductor.org>) was used to screen network motifs, which revealed a significant differential score between the CAD group and the normal control (P\<0.05) based on the gene expression data from microarrays ([@b17-etm-0-0-3299]). The significance of the network motifs was assessed by calculating random differential scores in 1,000 random disturbances.

### Functional analysis of genes involved in the differential network motifs

Genes involved in the resulting differential network motifs were subject to pathway enrichment analysis based on Kyoto Encyclopedia of Genes and Genomes (KEGG; [www.genome.jp/kegg](www.genome.jp/kegg)) ([@b18-etm-0-0-3299]) and functional annotation analysis based on the gene ontology (GO) database ([@b19-etm-0-0-3299]) using Database for Annotation, Visualization and Integrated Discovery (version 6.7; <https://david.ncifcrf.gov/>) ([@b20-etm-0-0-3299]). P\<0.05 was used as a cut-off.

### Comparison of the two classification method

Differential expression analysis of the genes of 13 patients with CAD and 11 asymptomatic controls was performed to screen DEGs (false discovery rate, \<0.05) using the significant analysis of microarrays (SAM) method ([@b21-etm-0-0-3299]). Subsequent to this, the patient and control samples were classified based on the resulting DEGs using a hierarchical clustering method. Further to this, the patient and control samples were also clustered based on the expression values of the top three-node network motifs detected in the present study and the expression value of a motif was defined as the mean of the expression values of the three genes within a motif. The clustering results of the two different methods were then compared.

Results
=======

### Genes annotated from gene microarrays

In total, 27,531 genes were annotated from the gene microarray data GSE42148.

### Genes annotated from gene microarrays and detection of three-node network motifs

A total of 27,531 genes were annotated from the gene microarray data GSE42148. An integrated regulation network was constructed using the final-screened common genes and the associated transcription factors, which consisted of 13,133 genes, including 76 transcription factors and 60,709 associated pairs, including 24,573 transcriptional regulation pairs and 36,136 protein-protein interaction pairs.

Finally, 9,008 three-node network motifs involving a total of 2,774 genes were detected, with each motif containing at least one transcription factor. The aforementioned network motifs may be categorized into 22 modes according to the pattern of interior molecular interaction ([Fig. 1](#f1-etm-0-0-3299){ref-type="fig"}).

### Screening of differential network motifs

A total of 1,132 differentially expressed network motifs involving 697 genes, between the CAD group and the control group were screened using R-package GlobalAncova software.

Of the 1,132 differential network motifs, there were 304 network motifs sharing the interaction pattern 100110222 (26.86%). In the mode 100110222, one transcription factor regulates two co-expressed target genes. The motif consisting of structural maintenance of chromosomes 3 (*SMC3)*, CCAAT/enhancer binding protein beta (*CEBPB)* and tribbles pseudokinase 1 *TRIB1* and that consisting of *IQCG*, Myc Associated Factor X (*MAX*) and *BAT3* \[also known as BCL2 associated athanogene 6 (*BAG6*)\] were of this type. Among the top 20 network motifs, 10 shared this mode. Furthermore, 228/1,132 (20.14%) differential network motifs shared the interaction pattern 100220212, in which two transcription factors regulates the same target gene. Among the top 20 network motifs, six shared this interaction mode, including the motif consisting of *USF1* and *USF2* and zinc finger protein 507 (*ZNF507*; [Table I](#tI-etm-0-0-3299){ref-type="table"}).

### Functional analysis of genes involved in the differential network motifs

The 697 genes involved in 1,132 differential network motifs were enriched in 154 GO terms, including 21 molecular function terms, 14 cellular component terms and 119 biological process (BP) terms, in addition to 14 KEGG pathways and various cancer pathways, including small cell lung cancer and the mitogen-activated protein kinase (MAPK) signaling pathway. Numerous genes were enriched in apoptosis-related BP terms, including *FADD* and *MYC*. Furthermore, 43 genes were enriched in the KEGG signaling pathway, including *FADD* and *MAX*.

### Comparison of the two classification methods

A total of 336 DEGs were screened using the SAM method. According to the hierarchical clustering based on these 336 DEGs, there was one control sample clustered in the patient group and three patient samples in the control group ([Fig. 2](#f2-etm-0-0-3299){ref-type="fig"}). Conversely, according to the clustering based on the top 20 three-node network motifs, there were two patient samples in the control group and no control samples in the patient group ([Fig. 3](#f3-etm-0-0-3299){ref-type="fig"}). Therefore, clustering based on the screened network motifs was demonstrated to be more accurate. Furthermore, only 38 genes in the top 20 network motifs were used compared with the 336 DGEs used for the clustering based on individual genes.

Discussion
==========

In the present study, 1,132/9,008 network motifs revealed a significant difference between the CAD group and the normal control, indicating that the aforementioned motifs may be associated with the occurrence of CAD.

Several studies have identified apoptosis in atherosclerosis, which is a typical pathological feature in patients with CAD ([@b22-etm-0-0-3299]--[@b24-etm-0-0-3299]). Various genes were demonstrated to be enriched in apoptosis regulation-related BP terms in the present study, including *FADD*. Previously, *FADD* was observed to have a role in cancer pathways ([@b25-etm-0-0-3299]). It was demonstrated that *FADD*, together with *CASP8* and *FADD*-like apoptosis regulator (*CFLAR*), was regulated by transcription factor 12 (*TCF12*) in a network motif. *FADD* mediates a death signaling pathway via its binding to the death domain of the Fas receptor ([@b26-etm-0-0-3299]), followed by the recruitment of *CASP8*. *CFLAR* encodes c-FLIP, which is a protein that regulates apoptosis and is structurally similar to caspase-8, yet possesses no caspase activity. c-FLIP is able to interfere with the death receptor signaling pathways via binding to *FADD* ([@b27-etm-0-0-3299]). c-FLIP expression has been reported in the smooth muscle cells of normal human coronary arteries and the downregulation of c-FLIP was observed in human atherosclerotic atheroma ([@b28-etm-0-0-3299]). As the two co-expressed genes are both regulated by *TCF12*, which encodes a protein belonging to the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG, this transcription factor may be associated with the occurrence of CAD.

BAT3 (also known as *BAG6*), which is a member of the Bcl-2 associated anthanogene family of proteins, has also been reported to regulate apoptosis via modulating ubiquitin-mediated proteolysis of the *Xenopus* elongation factor *Xenopus laevis* elongation factor 1α oocyte form in *Xenopus* embryos ([@b29-etm-0-0-3299]). However, to the best of our knowledge, its role in atherosclerosis has yet to be reported. In the motifs consisting of IQCG, MAX and BAT3, they are regulated by *MAX*. *MAX* encodes a transcription factor belonging to the bHLH leucine zipper family, which is a binding partner of c-Myc ([@b30-etm-0-0-3299]). c-Myc/MAX expression has been observed to be elevated by oxidized low-density lipoprotein, which is able to promote atherogenesis ([@b31-etm-0-0-3299]). In the present study, *MAX* was also demonstrated to function in CAD via cancer pathways, including small cell lung cancer and MAPK signaling pathways. *IQCG* was the second gene regulated by *MAX*. As it is co-expressed with BAT3, it is likely that this gene may also have a role in apoptosis.

Furthermore, dyslipidemia is also recognized as an important risk factor for CAD in the general population ([@b32-etm-0-0-3299]). The upstream stimulatory factor family *USF1*/*2* is a major transcription factor family that bind their target genes via the E-box element ([@b33-etm-0-0-3299]). *USF1*, is responsible for governing numerous genes involved in lipid and glucose metabolism ([@b34-etm-0-0-3299]), and has been confirmed to contribute to aortic atherosclerosis ([@b35-etm-0-0-3299]). However, the role of *USF2* in atherosclerosis has seldom been reported. *ZNF507* was observed to display a significant alteration in expression levels in response to elevated levels of homocysteine ([@b36-etm-0-0-3299]), which is considered to increase the risk of atherosclerosis ([@b37-etm-0-0-3299]). As the two transcription factors were co-expressed in the network motif, it may be inferred that *USF2* also has a role in atherosclerosis.

In conclusion, at least one gene in the screened network motif was associated with the pathological characteristics occurring in patients with CAD; thus, there is sufficient evidence to indicate that these screened network motifs may be useful as markers for identifying CAD. Further consolidation was provided by the clustering results, which revealed that the network motif-based method was more accurate and efficient, as compared with the conventional method based on individual DEGs. Therefore, the network motif-based method in combination with gene expression data may be a promising method for the diagnosis of CAD.
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###### 

Top 20 three-gene network motifs.

              Network motif                                        
  ----------- --------------- ----------- ------------- ---------- ---------
  100220212   *USF2*          *ZNF507*    *USF1*          9.2369   \<0.001
  100220212   *SMARCA4*       *SMARCB1*   *H3F3B*         7.4731   \<0.001
  100110222   *CTCF*          *MAP2K1*    *TRIB1*       12.1154    \<0.001
  100220212   *SMARCA4*       *SMARCB1*   *HIST1H2AE*     8.9551   \<0.001
  100220212   *TBP*           *H3F3B*     *NFYB*        11.2600    \<0.001
  100220212   *TBP*           *C1orf55*   *GTF2B*         9.6064   \<0.001
  100110222   *RAD23B*        *UBB*       *CEBPB*         7.4253   \<0.001
  100110222   *RAD23B*        *TAF1*      *ZFAND5*        6.9660   \<0.001
  100220222   *SMC3*          *CEBPB*     *TRIB1*       13.4760    \<0.001
  100110222   *IQCG*          *MAX*       *BAT3*        10.7233    \<0.001
  100110222   *TCF12*         *FADD*      *CFLAR*         6.8301   \<0.001
  101110022   *SGK1*          *SMARCA4*   *CREB1*         8.1492   \<0.001
  100210212   *ETS1*          *SP1*       *HIST1H2AE*     6.8723   \<0.001
  100220222   *CTCF*          *CEBPB*     *TRIB1*       12.1933    \<0.001
  100110222   *TAF1*          *EIF3D*     *EIF5*        15.9259    \<0.001
  100110222   *TAF1*          *CSNK2B*    *EIF5*        17.2414    \<0.001
  100110222   *TAF1*          *EIF4G2*    *EIF5*        17.0751    \<0.001
  100210212   *NR3C1*         *CEBPB*     *TRIB1*       12.7046    \<0.001
  100220222   *TRIB1*         *CEBPB*     *RAD21*       14.0708    \<0.001
  100110222   *GATA2*         *FOXO3*     *SGK1*          6.8563     0.001

Determined by permutation testing.
